VanEck ChiNext ETF (CNXT) Chart & Stock Price History → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free CNXT Stock Alerts $23.16 +0.73 (+3.25%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartHoldingsOwnershipStock AnalysisChartHoldingsOwnership VanEck ChiNext ETF Stock Price Performance5 Day Performance+3.63%1 Month Performance-0.82%3 Month Performance+6.74%6 Month Performance-2.23%Year-To-Date Performance-5.53%1 Year Performance-23.83% Receive CNXT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck ChiNext ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> CNXT Stock Chart for Friday, April, 26, 2024 CNXT Chart by TradingView VanEck ChiNext ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$22.43$23.16+3.25%$23.21$23.148,154 shs$15.05 million04/25/2024$22.37$22.43+0.27%$22.43$22.341,427 shs$14.58 million04/24/2024$22.32$22.37+0.22%$22.41$22.361,805 shs$14.54 million04/23/2024$22.25$22.32+0.31%$22.32$22.256,123 shs$14.51 million04/22/2024$22.35$22.25-0.45%$22.25$22.16892 shs$14.46 million04/19/2024$22.71$22.35-1.59%$22.38$22.321,624 shs$14.53 million Get the Latest News and Ratings for CNXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VanEck ChiNext ETF and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$22.87$22.71-0.70%$22.78$22.591,187 shs$14.76 million04/17/2024$22.32$22.87+2.46%$22.88$22.861,623 shs$16.01 million04/16/2024$22.80$22.32-2.11%$22.33$22.266,064 shs$15.62 million04/15/2024$22.07$22.80+3.33%$22.80$22.762,153 shs$15.96 million04/12/2024$22.59$22.07-2.32%$22.43$22.0625,804 shs$15.45 million04/11/2024$22.60$22.59-0.04%$22.62$22.473,976 shs$15.81 million04/10/2024$23.31$22.60-3.05%$22.76$22.56970 shs$15.82 million04/09/2024$23.05$23.31+1.12%$23.31$23.112,794 shs$16.32 million04/08/2024$23.38$23.05-1.40%$23.05$23.022,268 shs$16.14 million04/05/2024$23.46$23.38-0.34%$23.42$23.351,084 shs$16.37 million04/04/2024$23.42$23.46+0.17%$23.52$23.46465 shs$16.42 million04/03/2024$23.68$23.42-1.10%$23.50$23.322,441 shs$16.39 million04/02/2024$23.79$23.68-0.46%$23.72$23.64945 shs$16.58 million04/01/2024$22.96$23.79+3.61%$23.87$23.774,812 shs$16.65 million03/29/2024$22.96$22.96$23.10$22.955,997 shs$16.07 million03/28/2024$22.73$22.96+0.99%$23.10$22.955,997 shs$16.07 million03/27/2024$23.35$22.73-2.65%$22.86$22.692,820 shs$15.91 million03/26/2024$23.27$23.35+0.35%$23.36$23.344,832 shs$16.35 million03/25/2024$23.62$23.27-1.47%$23.41$23.112,674 shs$16.29 million03/22/2024$24.09$23.62-1.95%$23.68$23.612,001 shs$16.53 million03/21/2024$24.40$24.09-1.27%$24.13$24.045,795 shs$16.86 million03/20/2024$24.36$24.40+0.16%$24.40$24.33248 shs$17.08 million03/19/2024$24.61$24.36-1.02%$24.36$24.31493 shs$17.05 million03/18/2024$24.16$24.61+1.88%$24.77$24.448,868 shs$17.23 million03/15/2024$24.01$24.16+0.62%$24.17$24.002,954 shs$16.91 million03/14/2024$24.22$24.01-0.87%$24.22$24.011,172 shs$16.81 million03/13/2024$24.38$24.22-0.66%$24.28$24.221,907 shs$16.95 million03/12/2024$24.41$24.38-0.12%$24.54$24.351,873 shs$17.07 million03/11/2024$23.05$24.41+5.90%$24.44$24.0814,628 shs$17.09 million03/08/2024$22.93$23.05+0.53%$23.07$23.05347 shs$16.14 million03/07/2024$23.42$22.93-2.10%$23.09$22.892,540 shs$16.05 million03/06/2024$23.34$23.42+0.36%$23.42$23.42784 shs$16.39 million03/05/2024$23.40$23.34-0.27%$23.40$23.332,297 shs$16.34 million03/04/2024$23.34$23.40+0.25%$23.42$23.393,835 shs$16.38 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>03/01/2024$23.05$23.34+1.26%$23.35$23.256,129 shs$16.34 million02/29/2024$22.32$23.05+3.27%$23.06$23.034,136 shs$16.14 million02/28/2024$22.96$22.32-2.79%$22.67$22.291,766 shs$15.62 million02/27/2024$22.40$22.96+2.50%$22.97$22.903,811 shs$16.07 million02/26/2024$22.49$22.40-0.38%$22.48$22.363,605 shs$15.68 million02/23/2024$22.49$22.48-0.06%$22.48$22.481,089 shs$15.73 million02/22/2024$22.45$22.49+0.18%$22.54$22.4519,241 shs$15.74 million02/21/2024$22.32$22.45+0.58%$22.48$22.3310,325 shs$15.72 million02/20/2024$22.40$22.32-0.36%$22.34$22.32655 shs$15.62 million02/19/2024$22.40$22.40$22.45$22.214,200 shs$15.68 million02/16/2024$22.13$22.40+1.22%$22.45$22.214,225 shs$15.68 million02/15/2024$22.03$22.13+0.45%$22.23$22.131,687 shs$15.49 million02/14/2024$21.98$22.03+0.23%$22.03$21.981,744 shs$15.42 million02/13/2024$22.06$21.98-0.36%$22.13$21.951,587 shs$15.39 million02/12/2024$21.90$22.06+0.75%$22.10$21.924,492 shs$15.44 million02/09/2024$21.92$21.90-0.09%$21.92$21.751,315 shs$15.33 million02/08/2024$21.81$21.92+0.50%$22.00$21.824,931 shs$15.34 million02/07/2024$21.46$21.81+1.63%$21.89$21.784,813 shs$15.27 million02/06/2024$19.94$21.46+7.62%$21.48$21.2311,608 shs$15.02 million02/05/2024$19.69$19.94+1.27%$19.99$19.762,452 shs$13.96 million02/02/2024$20.47$19.76-3.47%$19.76$19.653,183 shs$13.83 million02/01/2024$20.24$20.47+1.14%$20.47$20.451,576 shs$14.33 million01/31/2024$20.34$20.24-0.50%$20.32$20.243,544 shs$14.17 million01/30/2024$20.82$20.34-2.30%$20.45$20.334,493 shs$14.24 million01/29/2024$21.70$20.82-4.07%$21.07$20.7811,723 shs$14.57 million01/26/2024$22.15$21.70-2.03%$21.79$21.694,158 shs$15.19 million01/25/2024$22.34$22.15-0.85%$22.26$22.133,611 shs$15.51 million Related Companies: PJFV Stock Chart FPA Stock Chart FEUZ Stock Chart EMFM Stock Chart PJIO Stock Chart FGM Stock Chart ATFV Stock Chart PEMX Stock Chart FDG Stock Chart FCA Stock Chart Receive CNXT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for VanEck ChiNext ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:CNXT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck ChiNext ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.